DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Appeal No. 7023 of 2026 filed by Vivek Tripathi

SEBI 4d ago·3 Sept 2026, 12:33 pm

Company SEBI

A legal appeal has been filed in the Supreme Court by an individual named Vivek Tripathi, designated as Appeal No. 7023 of 2026. This is a formal request to review a previous court decision, though the specific details of the underlying case are not provided in the headline.

For the broader market, this development is currently a matter of public record but does not carry immediate, specific implications for individual company performance. It is a standard procedural step in the judicial process.

Investors should monitor the case for updates, but given the lack of specific details, it is too early to assess any potential impact on stock prices or market sentiment.